Latest News

December 20, 2010
In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ. The method allowed the team to observe, for the first time, both the live interaction of living cells in the context of their environment and the unfolding of events in the immune response to lung injury.
September 21, 2010
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.
July 16, 2010
Results of a clinical trial through the UCSF-sponsored Immune Tolerance Network may offer the first new treatment in 40 years for the devastating blood vessel disease known as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
July 14, 2010
UCSF is accepting applications up to August 1 for the kick-off of a new Doctoral Program in Epidemiology and Translational Science this fall.
July 07, 2010
Americans with lung disease may face a far greater level of lung damage than either they or their doctor suspect, depending on their individual genetic heritage, according to a study released July 7. The research implications range from diagnosing the severity of asthma to disability decisions or eligibility for lung transplants, researchers say.
June 24, 2010
The oil spill crisis in the Gulf Coast underscores the importance of implementing effective regulation through a proactive strategy to protect public health, according to UCSF’s Paul Blanc, the author of a re-released book.
April 22, 2010
Insight into pneumonia deaths due to antibiotic-resistant Staphylococcus aureus infections emerges from UCSF study.
March 25, 2010
UCSF has appointed Jeffrey A. Bluestone, PhD, a preeminent scientist and proven campus leader, as UCSF executive vice chancellor and provost.

Pages